Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019Lina van der Straten, Avinash G. Dinmohamed, Mark‐David Levin et al.|Blood Cancer Journal|2023Cited by 36
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLLLina van der Straten, Mark‐David Levin, Harry R. Koene et al.|Blood|2023Cited by 27
Survival continues to increase in chronic lymphocytic leukaemia: a population‐based analysis among 20 468 patients diagnosed in the Netherlands between 1989 and 2016Lina van der Straten, Avinash G. Dinmohamed, Mark‐David Levin et al.|British Journal of Haematology|2020Cited by 18
Long-term trends in the loss in expectation of life after a diagnosis of chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989–2018Lina van der Straten, Avinash G. Dinmohamed, Carolien C. H. M. Maas et al.|Blood Cancer Journal|2022Cited by 12
Conditional relative survival among patients with chronic lymphocytic leukaemia: A population‐based study in the NetherlandsLina van der Straten, Avinash G. Dinmohamed, Mark‐David Levin et al.|eJHaem|2021Cited by 9